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Abstract
The use of plasma rich in growth factors has become a technique increasingly used in var-
ious fields of medicine. Since its inception in use in sports medicine and dental implants 
in the mid-80s, gradually it has expanded its field of use in clinical specialties. The power 
cell tropism for certain tissues, attributed to growth factors, has currently talked of a new 
medical discipline as Regenerative Medicine. Not only has experienced an ever increas-
ing boom in various medical specialties, but simultaneously has increased exponentially 
types and methodology for obtaining application forms even for the same pathology. So 
much so that now its use has exceeded the capacity to produce scientific evidence for 
successful clinical application.
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1. Introduction
The use of plasma rich in platelet growth factors has become a technique increasingly used in 
various fields of medicine. Since its inception in use in sports medicine and dental implants 
in the mid-80s, gradually it has expanded its field of use in clinical specialties as diverse as 
otolaryngology, plastic surgery and dermatology, general surgery, ophthalmology, obstetrics 
and gynecology or neurosurgery between other. The power cell tropism for certain tissues, 
attributed to growth factors, has currently talked of a new medical discipline as regenerative 
medicine. Not only has experienced an ever increasing boom in various medical specialties, 
but simultaneously has increased exponentially types and methodology for obtaining appli-
cation forms even for the same pathology. So much so that now its use has exceeded the 
capacity to produce scientific evidence for successful clinical application. The objective of this 
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work is to review the clinical applications where there has been more scientific evidence and 
those where although still lack solid scientific basis are interesting from the point of view of 
clinical and preclinical.
2. Fields of application of platelet RICH plasma
They are numerous and ever growing fields where PRP is being implemented and its various 
fractions. Let us review for specialty applications where there seems to be more consensus, 
emphasizing those where there is scientific evidence of greater support; furthermore task not 
without difficulty given the controversy in the medical community even for the same clinical 
application and the absence of scientific studies weight as properly designed clinical trials 
for this purpose; although as will most indications are based on case series and even isolated 
clinical cases difficult to reproduce by the authors as to design more scientific studies force.
2.1. Rheumatology, traumatology or sports medicine
This is certainly the field of greatest projection in the use of PRP, far surpassing even the 
existing clinical evidence. In vitro PRP shown to regulate cytokine processes involved in neo-
vascularization, proliferation of tenocytes, fibroblasts, myocytes and chondrocytes, and the 
recruitment of inflammatory cells with inhibitory effect of proinflammatory cytokines (IL-1) 
with anti-inflammatory and regenerative activity (Tables 1 and 2).
2.1.1. Epicondylitis
Epicondylitis is a tendinopathy limiting, with a clear tendency to become chronic and random 
partial response to conventional therapy with steroid injections and rehabilitation. Studies 
using PRP in these patients as single infiltration resulted in significant functional improve-
ment in analgesic and 85% of them without imparting any adverse effect. Further deepening 
is necessary anyway, since existing studies contained small numbers of patients [1, 2].
2.1.2. Plantar fasciitis
As in the rest of tendinopathy with a tendency to become chronic, has reviewed a study of 
a case series of patients with plantar fasciitis refractory to treatment with NSAIDs, immobi-
lization, physical therapy and corticosteroid infiltration, who are PRP infiltrated with a sig-
nificant functional improvement and pain in 90% of them. Also in this case more studies are 
needed to objectify the benefit in this pathology [3, 18].
2.1.3. Knee osteoarthritis
A relatively new application that is currently bringing together most of the current clinical 
research. Case series studies of patients compared with single infiltration of hyaluronic acid, 
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document up to 35% of respondents to the PRP infiltrate, compared with 10% hyaluronic 
acid. While these studies collect causística few patients, the importance is that for the first 
time the concentrations of growth factors contained in PRP infiltrated specified, stressing 
the importance of leukocyte fraction not potentiate the proinflammatory effect of the final 
product obtained. In recent years most extensive series of clinical cases have reported their 
success in implementing PRP injections; perhaps the largest series the Spanish belonging to 
a group that included the treatment of 261 patients with 3 injections of PRP 15 days set apart 
from each other, with a follow up of 1 year, with a functional improvement in 67% of them, on 
especially those younger patients and those with a more incipient development of the disease 
[4–6, 11, 15, 16].
Area Clinical applications Scientific evidence
• Skeletal muscle pathologies • Tendinopathies
• Meniscopathy
• Ligament injuries
• Bone fractures
• Fasciitis
• Muscle tears
• Osteoarthritis
• Preclinical and clinical 
Studies (cases-control)
• Surgical wounds • Gynecological surgery (abdominal)
• Cardiovascular surgery (sternal and 
vascular access)
• Plastic surgery (skin flap)
• Clinical studies (case series).
• Burns • Skin and corneal • Clinical studies (clinical 
isolates).
• Chronic ulcers • Diabetic
• Vascular
• For pressure
• Clinical Studies 
(Case-control)
• Ophthalmology • Corneal ulcers
• Dry eye
• Preclinical and clinical stud-
ies (case series)
• Otolaryngology • Tympanoplasty • Preclinical and clinical stud-
ies (case series)
• Cosmetic surgery and 
dermatology
• Facial expression lines
• Hair Implants
• Preclinical and clinical stud-
ies (case series).
• Neurology and neurosurgery • Suture of peripheral nerves and 
neurorehabilitation
• Preclinical and clinical stud-
ies (clinical isolates)
Table 1. Applications of PRP in different fields of medicine and scientific evidence.
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Study Results Authors
• Tendinopathy 
chronicle
• Injury chronic more than 6 
weeks.
• Refractory epicondilitis
• Chronic pain lateral epicondyle.
• Achilles tendinopathy.
• Progress of a patient with 
Achilles rupture.
• PRP vs. saline infiltration.
• Chronic refractory tendinitis: 
PRP vs. saline infiltration.
• 97% good results
• 8% poor results.
• 79% success rate.
• 60% improvement at 
8 weeks, 81% at 6 months 
and 93% at 12 months.
• PRP did not generate dam-
age and faster recovery.
• Regeneration and faster 
return to activity.
• Same results though less 
inconvenience.
• No significant differences.
• Gandia and col.
• Edwards y 
Calandruccio.
• Mishard and 
Pavelko.
• Sanchez and col.
• Filardo and col.
• De Vos and col.
• De Jonge and col.
• Patellar 
tendinitis
• Animal study.
• Plasma in rat patellar tendon.
• 20 athletes with chronic patellar 
tendinitis (three injections of 
PRP).
• Patellar tendon in 31 patients 
during 6 months.
• PRP vs. Others treatments.
• Greater immunogenic 
response without abnormal 
marcadors.
• Increased levels of collagen 
I and II.
• 70% complete recovery at 
6 months, the rest 80% with 
decreased pain.
• Better results and better 
quality.
• PRP more effective in degen-
erative conditions
• Taylor and col.
• Kajikawa and col.
• Kon and col.
• Filardo and col.
• Van Ark and col.
• Elbow 
tendinitis
• Corticosteroid injections vs. PRP.
• Using PRP in epicondylitis.
• PRP Injections vs. corticosteroids 
infiltrations.
• 79% good results with PRP 
vs. 51% with corticosteroids.
• Increased angiogenesis, 
wound healing and acceler-
ates higher histological 
grade.
• Long-term benefits.
• Gosens and Perbons.
• Lyras and col.
• Coombes and col.
• Plantar 
fasciitis
• Cronica.
• PRP vs. another treatments.
• Chronic plantar fasciitis.
• 6/9 symptomatic relief als 
8 weeks and 77.9% complete 
resolution of symptoms a 
year.
• Best treatment to avoid 
relapses.
• Ecure method and reduces 
pain.
• Barret and Erredge.
• Glazer and col.
• Martinelli y col.
• Ligament 
acute injury
• ACL reconstruction.
• ACL reconstruction.
• Shortening the return to 
activity by 27%.
• There is no consensus, faster 
transformation of LCA with 
PRP.
• Samspson and col.
• Ventura and col.
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2.1.4. Other applications
It has been seen that the PRP is useful in chronic Achilles tendinopathy especially when infil-
trations Ozone [8, 9, 10], patellar tendinopathy [5, 6, 11], previously used in repairing cuff 
rotators [12, 13, 14], repair the anterior cruciate ligament [11] or with plasty erector or tibial 
bone-tendon graft-bone, meniscal repair the knee joint [5, 6], in the reconstruction of the gle-
noid labrum or hip and ultimately partial and total muscle injury made here open repair and 
strengthening PRP later [7, 19].
2.2. Chiropody
In most cases, the goal of medical research is not only to extend the patient’s life, but to 
improve the quality of the patient. Growth factor rich plasma is a novel and relatively recent 
technique applicable to tissue repair. It consists of a simple system for obtaining platelet and 
autologous plasma proteins from a patient’s blood sample. In the field of podiatry the appli-
cation of PRGF allows to improve the evolution of patients with regenerative needs in lower 
limbs such as: accelerate ossification postoperatively, shorten the resolution time in diabetic 
ulcers or improve scarring among many others. Several studies on the application of growth 
factors have shown excellent results in different medical specialties among which podiatry is 
found; therefore it is considered a technique of high effectiveness and clinical interest for its 
contribution to the scientific community [17].
2.3. Dentistry and maxillofacial surgery
Maybe another field where the PRP has seen a more visible development. However there is a 
strong controversy and debate as to the usefulness of the PRP in the recovery of dental alveo-
lar bed with lyophilized bone plasty, objectifying alveolar increased, improving the healing 
of the soft tissues and facilitating greater cohesiveness particulate graft, which would useful 
in dental implantology. Others are more pessimistic when it comes to reproduce these results, 
due to the large differences in growth factors present in the PRP, according to the method of 
obtaining the final product applied [20–23]. This led to think that the higher the concentration 
of these factors would be more effective regeneration, promoting the use of systems that got a 
Study Results Authors
• Muscle 
injuries
• 11 elite athletes with muscle 
tears.
• 20 professional athletes.
• 8 football players and 6 of 
basketball.
• PRP in animals.
• Return to the fastest com-
petition and 30% shortens 
recovery
• Good results.
• Faster return to competition.
• It shortens the recovery 
period of the muscle.
• Wright-Carpenter.
• Sanchez and col.
• Cugat and col.
• Hammond and col.
Table 2. Applications PRP in trauma and orthopaedic surgery.
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higher concentration of growth factors, systems that were approved and used without think-
ing of the concentration obtained product end. Far from achieving the desired effect, in vitro 
otherwise completely it observed when the concentration factor exceeds a certain level. Hence 
the strong controversy arose in its use in many cases fueled by the lack of systematic obtaining 
PRP that may be incorrect.
2.3.1. Aggressive periodontitis
Platelet-rich plasma has emerged as an alternative in periodontal therapy. PRP appears to 
increase the speed of the healing process since it is biologically possible that a higher concen-
tration of platelets can assist in wound healing due to the higher concentration of platelets 
and initiate a faster cellular response than the normal blood clot [6, 7]. Today we have an 
evidence-based learning curve that shows us a first stage where it was used as a cementing 
biomaterial and as a stimulant for the regeneration of bone tissue. In a second stage, it is 
applied for the healing of soft tissue wounds based on biological evidence, which has gener-
ated great expectations in several medical specialties, among which is dentistry. The clinician 
today increasingly understands the need to make decisions based on scientific evidence. Until 
now, we know that biologically it is possible that a higher concentration of platelets can aid 
in healing.
2.3.2. Dental implants
In the field of Implantology, we report the use of PRP in the preparation of maxillary bone 
for placement of implants; thus it is described that in the alveoli to which PRP are placed 
they show a greater buccolingual/palatal bone width, accompanied by a higher bone den-
sity and a faster tissue coverage compared to patients in whom this compound was not used 
[33]. Probably, the benefits of PRP on implants may be related to the type of bone on which 
they act, since most of the studies that show better clinical indices correspond to sites with-
out grafts or autologous grafts where factors such as vascularization may play an important 
role. In a radiographic clinical study of 11 patients who were implanted in the posterior 
mandibular area without grafting, no implant failure was observed, and it was shown that 
the use of PRP may lead to early bone apposition around the implant, and that improves 
soft tissue healing. Previous in vitro studies have demonstrated a PRP stimulatory effect 
on osteoblast proliferation that appears to begin in vivo at the second week, increase from 
the third week, and is maintained during the fourth week, so the local application of PRP 
would increase the amount of newly formed bone around the implant and bone density. In 
studies on canines, it has been observed that the application of PRP significantly increases 
the contact between bone and implant (P = 0.028). B15. In the dental area, most studies 
have focused on bone regeneration. With respect to the use of plasma in sinus elevation 
and increased alveolar ridge published a study that determined the advantages of its use 
in conjunction with lyophilized bone, but also indicate that it is necessary to have more 
studies that support this method. With regard to repair of bone defects and use of PRP in a 
study with 10 patients with diagnosis of periodontitis we used bone graft associated with 
PRP in the cases group, and bone graft and serum in the control group. Comparatively a 
greater reduction of the sacks and better quality of bone was obtained in the patients of 
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the case group with respect to the control group. Evaluated the use of PRP with tricalcium 
phosphate compared with the use of alloplastic material only in intraosseous defects. They 
conclude that the associated use of the materials presents better clinical and radiographic 
results. Conducted a study in which they evaluated the ability to reduce bone resorption in 
fractured alveoli, in a case group of 14 people who used PRP compared to 6 people in whom 
it was not used. It was concluded that the use of PRP decreases bone resorption.
Several clinical procedures have used the PRP observing their qualities in the dental area. 
Presented platelet gel for use as an adhesive in bone grafts and one that aided the consolida-
tion. The platelet gel is obtained and processed immediately in the operating room. Marx 
et al. [23] observed that a platelet concentrate obtained by blood centrifugation caused a high 
concentration of platelets in the graft and with them, the presence of growth factors and that 
the cells of the spongy bone also possess receptors for these.
It was also described that the use of PRP and PRF offer a new and useful therapeutic tool 
in the acceleration of healing and bone maturation in maxillofacial and reconstructive sur-
gery. In this regard, Marx et al.  and Fennis et al. [29], demonstrated that PRP improves 
bone regeneration and that platelets can act as local regulators of the healing process; in 
turn, the application of the PRP and the CFs it contains, increase the microcirculation of the 
gingival mucosa surrounding the wound. Other studies have shown that with a single 20 
pM application of a recombinant factor PDGF-BB type, a significant effect can be achieved 
in increasing capillary density. A similar effect could be achieved in patients treated with 
PRP [30]. The characteristics of the PRP suggest that it could be of great use in implant 
procedures, and generally in procedures involving the preservation of bone and soft tis-
sue. The use of PRP has several advantages such as a safe autogenous preparation, free of 
worries about communicable diseases such as HIV, hepatitis or Creutzfeldt-Jakob disease; 
and is convenient for the patient, since the blood is collected in the immediate preopera-
tive. However, although PRP therapy has been used for decades, there is no agreement in 
the literature as to whether this procedure influences the success of bone integration of an 
implant. Our observations have shown lower rates of failure with the use of PRP compared 
to the conventional technique without PRP, although this difference is not statistically sig-
nificant and, although the calculated risk and treatment measures show a beneficial effect 
of PRP, it is reduced.
2.3.3. Periodontics
In the field of periodontics, the use of PRP has been described as adjuvant of regenerative 
therapy. Some authors found that there was a significantly greater increase in the periodon-
tal ligament when the injured sites were treated with PRP [31, 32]. Since the beginning of 
the research with the PRP, studies have been published that showed optimal results in bone 
regeneration with its application alone or combined with grafting. In general, most of the 
studies where PRP is applied agree that there is a visible improvement of soft tissue healing 
and a greater cohesiveness of the particulate grafts, since it facilitates their manipulation and 
transport to the surgical bed; however, it is important to emphasize that the real role of growth 
factors is in relation to differentiated cells (preosteoblasts or osteoblasts), promoting their 
proliferation and differentiation and not on the stem cells of the tissue (able to differentiate 
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into cells of the bone tissue), which would explain some controversies regarding the main 
role of these factors in the formation of bone tissue. However, the application of PRP in the 
specialty of periodontics continues to be of great utility since it behaves as a matrix for par-
ticulate grafts in the regeneration of bone defects (GTR) left by periodontal disease and in the 
area of periodontal cosmetic surgery (for root coverage), where it has been reported that it 
may be a good alternative to connective tissue grafts in root coverage surgery to promote the 
formation of lost soft tissues and decrease postoperative inflammatory response, as reported 
in the studies reviewed.
2.4. Gynecology
Gels have been used for handling PRP surgical wounds in various major surgeries, with posi-
tive effects on aspects like reduction in postoperative pain with less conventional analgesic 
requirement. In a case-control study, application of recombinant PDGF gels in dehiscence 
abdominal surgery, showed a significantly shorter closure, compared to controls, no signifi-
cant side effects [24, 25].
Furthermore the PRP has been used in vitro as “plug” in the management of premature rup-
ture of fetal membranes, watertight sealing of defects in biological membranes [26].
However it has not been informed of the effect of PRP in areas such as infection or trans and 
postoperative bleeding.
2.5. Cardiovascular surgery
While it has been used to promote healing of cardiovascular surgical wounds, especially at 
the sternal level, but also in wounds caused by peripheral vascular access, several studies 
have shown that the topical application of PRP decreases the frequency of chest infection, 
improves hemostasis, postoperative pain, the amount of wound drainage and even decreases 
the days of postoperative hospital stay. Although studies have not shown a significant effect 
on the management of these [21, 27].
2.6. Plastic surgery
In a case series, we observed that the application of a skin flap on a surgical bed which was 
previously applied PRP, qualitatively reduced the volume of capillary bleeding from the sur-
gical bed, decreased need for drainage or compression bandages, as well as a reduction in 
postoperative pain [28].
On the other hand there are few studies strongly demonstrating the usefulness of PRP in the 
management of burns. Experimental studies have shown that applying a gel burns PRP stim-
ulates an intense inflammatory response, with a significant increase of extracellular matrix 
proteins, fibroblast proliferation, collagen and granulation tissue. However it has not docu-
mented a real acceleration epithelialization of wounds. On the other hand, a study that applied 
the subconjunctival injection of PRP in 10 patients with ocular burns showed a significantly 
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faster epithelialization of the cornea and the conjunctiva [26]. Another study that addressed 
the use of PRP gel for wound management including friction burns demonstrated a signifi-
cant improvement in its use [27]. Until now, there are no other studies that support the utility 
of PRP in burns. However, due to the good experimental results, there is a theoretical possibil-
ity that due to the reported increase in inflammatory action this could stimulate the formation 
of hypertrophic scarring in superficial burns and in deeper burns [27].
Therefore there is still no strong scientific evidence to recommend the PRP in the management 
of burns. There are variables such as type of scarring, burn extent, thickness thereof, time of 
application or rate of infection that still require more in-depth study [37].
2.7. General surgery
It has been postulated that the use of PRP as rich fibrin glue for placing meshes in correcting 
inguinal hernias material improves tolerance, postoperative pain, decreasing the amount of 
suture material for fixing the same, however even better designed studies are needed to refine 
this clinical application [31].
On the other hand it seems to be well-founded scientifically use in both diabetic ulcers, how 
in pressure ulcers, significantly speeding up the closure of the same, decreasing the pain with-
out significant side effects. Several studies, including a meta-analysis, have shown that the 
application of PRP in chronic diabetic ulcers significantly accelerates their closure, decreases 
pain and even works in the most severe wounds without significant collateral events reported 
[28]. A study that analyzed the cost of this therapy over conventional treatment over 5 years 
showed that the management of PRP improves the quality of life of these patients significantly 
and significantly reduces the costs of their care [29]. Evidence for the efficacy of platelet-rich 
plasma in these chronic lesions does not appear to be contradictory, so that PRP treatment in 
diabetic ulcers is well founded, however it remains unknown whether this overall effect of 
PRP on chronic wounds, if its beneficial effects are maintained in the long term, decreasing the 
percentages of amputation or if the outcome may be influenced by other factors of the wound, 
concomitant treatment or the particular patient. In this sense, a recent study that included 49 
patients with chronic wounds of various etiologies (pressure ulcers, venous ulcers, diabetic 
ulcers, etc.) also demonstrated the degree of improvement (area reduction, wound closure) in 
97% of cases regardless of wound origin [29, 30].
2.8. Ophthalmology
Experimental studies in vitro demonstrated that PRP increases the migration of fibroblasts 
and conjunctival keratinocytes. Similarly, some clinical studies have objectified positive 
effects of PRP in corneal ulcers and keratoconjunctivitis sicca Sjogren’s syndrome, for which 
there is currently no satisfactory treatment [33, 35].
In the case of eye burns subconjunctival injection of PRP in a number of patients showed 
significantly more rapid epithelialization of the cornea and conjunctiva, however this has not 
been demonstrated later [32].
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2.9. Otolaryngology
On preclinical and clinical use in type 1 patients with perforated eardrum Tympanoplasty 
studies could be useful in defect closure, however still required study more scientific evidence 
to corroborate this fact, not having such studies with controls [34, 36].
2.10. Dermatology
Experimental studies have shown that dermal papilla cells exposed to significantly increase 
their proliferation PRP, which was associated with increased Akt and ERK signaling and 
upregulation of fibroblast growth factor 7 and the B-catenin, which are recognized hair 
growth factors. Even though scientific studies are needed more power, PRP opens a range of 
possibilities in the treatment of psoriasis, vitiligo, alopecia, lichen planus and other cosmetic 
applications [28, 39].
2.11. Neurology and neurosurgery
Preclinical experimental studies have shown healing capacity and neuroregeneration with 
functional recovery in applying jointly PRP and suturing the edges of the injured nerve, due 
to a significant increase of axons in the distal segment, however these studies are still experi-
mental, although it has documented some isolated case report with positive results. Similarly 
this opens a door to the possibility of nerve stimulation in patients with neurological hypoxic 
ischemic tare origin especially following active neurorehabilitation programs. Still needed 
are appropriately supported in this respect clinical trials to assess the potential clinical benefit 
that PRP can contribute in this field [38, 40].
2.12. Anesthesiology
Nerve growth factor (NGF) is the founding member of the neurotrophin protein family. It 
was discovered over half a century ago through its ability to promote sympathetic and sen-
sory neuronal survival and axonal growth during the development of the peripheral nervous 
system, and are the paradigmatic neurotrophic factor-derived targets underlying the neuro-
trophic hypothesis. Since that time, NGF has also been shown to play a key role in the genera-
tion of acute and chronic pain and in hyperalgesia in various pain states. NGF is expressed at 
high levels in damaged or inflamed tissues and facilitates the transmission of pain by nocicep-
tive neurons through a variety of mechanisms. Genetic mutations in NGF or its receptor TrkA 
tyrosine kinase, lead to a lack of congenital sensitivity or a decrease in the ability of humans 
to perceive pain. B16. In humans, NGF levels are elevated in a variety of acute and chronic 
pain states including rheumatoid and spondyloarthritis in neurogenic overactive bladder and 
interstitial cystitis induced cancer pain prostatitis and in patients with degenerative interver-
tebral disc disease (Lee et al. [38]). The functional link between these increased levels of NGF 
and pain was determined through a variety of animal and human studies that modulate NGF 
levels and observe the resulting effects on the level of pain experienced. In humans, intramus-
cular injections of NGF in one trial resulted in an increase in pain scores and increased pres-
sure pain sensitivity in NGF injected muscle compared to baseline; these effects were resistant 
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to local muscle anesthesia. NGF also induced localized and long-lasting non-inflammatory 
mechanical and thermal hypersensitivity in human skin after local injection. Similarly, local 
injection of NGF into the masseter muscle induced mechanical allodynia and hyperalgesia 
that persisted for at least 7 days after administration of NGF B16. The results of clinical trials 
of tanezumab (a monoclonal antibody that sequesters NGF and does not let it act) that are 
currently underway, particularly those related to the progression of arthritis or osteonecrosis, 
are the next determinant of if and when realized that potential. In the event that tanezumab is 
shown to have an acceptable long-term safety profile. The key role of tanezumab in the man-
agement of pain in patients with chronic diseases may depend on a greater understanding of 
their different effects on symptom control (i.e., analgesia) vs. disease modification (chronic 
pain or persistence) B16.
2.13. Other applications
From the standpoint of experimentation, the scientific evidence regarding the role of PRP in 
stimulating proliferation of various cell lines both epidermal and mesenchymal, have been 
used as a support for growing and clonal expansion in vitro of same laboratory.
3. Conclusion
Surely we are facing a new era of treatment in the new field of what is called regenerative 
medicine with an extraordinary range of possibilities for clinical applications increased, but 
that requires a process of scientific and medical systematization which allows channel it 
safely and effectively in applications where there is scientific evidence really enough weight 
so apply. To do this it is necessary to two things: first the consensus of the authors engaged in 
the production and application of this therapy in order to standardize procedures for obtain-
ing those more effective and allow adequate traceability and monitoring of the end product, 
depending clinical application given their intended and secondly the design of clinical trials 
which management and establish appropriate guidelines to that effect.
Today we are still far from achieve, given that almost all existing clinical applications, the 
scientific evidence is weak, based on case series or case-control studies in the most posi-
tive assumptions. The growing presence of various protocols to obtain, low control over 
the final product component and variety of clinical applications, difficult first reach some 
sort of consensus on the process or procedures more reliable and adequate collection and 
secondly development of appropriate clinical trials to test them in different pathologies 
susceptible to it.
Revised everything published about the conclusion you reach is that the PRP is well tolerated 
technique, considered from 2 years as a medicine ago, restricted its use to prescribing physi-
cians, dentists and podiatrists, lacking tab Currently technique, and cannot be considered 
standard treatment for any medical condition where intended to be used, if it is accepted that 
it can be used as adjunctive therapy along with conventional therapies to implement clinical 
and functional improvement of the patient.
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They are necessary in the future of basic research and translational medicine to better under-
stand the pathophysiological mechanisms underlying its regenerative effects.
Similarly sheet to establish a sound scientific studies are necessary in the form of clinical trials 
to standardize the techniques for obtaining both depending on the cellular composition of the 
final product as a protein obtained and is reproducible by all authors and specific manage-
ment guidelines for each clinical application where feasible use in regenerative medicine.
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